| scholarly article | Q13442814 |
| P2093 | author name string | K Nakamura | |
| K Tamaki | |||
| A Asahina | |||
| H Torii | |||
| T Kakinuma | |||
| Y Tada | |||
| H Saeki | |||
| H Mitsui | |||
| M Wakugawa | |||
| M Komine | |||
| P2860 | cites work | Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells | Q24321607 |
| Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4 | Q28259171 | ||
| Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis | Q28266324 | ||
| Chemokines: a new classification system and their role in immunity | Q29615663 | ||
| Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity | Q32156624 | ||
| Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions | Q33859449 | ||
| Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis | Q34229692 | ||
| Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines | Q40911373 | ||
| Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation | Q40945513 | ||
| Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells | Q40994319 | ||
| Atopic dermatitis: immunobiology and treatment with immune modulators. | Q41341265 | ||
| Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis | Q41574850 | ||
| STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. | Q50335928 | ||
| Soluble intercellular adhesion molecule-1 and soluble E-selectin levels in patients with atopic dermatitis. | Q51019512 | ||
| Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3– and CC chemokine receptor 4–independent manner | Q58201531 | ||
| Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses | Q59713952 | ||
| Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis | Q68100710 | ||
| Responsiveness to interleukin 4 and interleukin 2 of peripheral blood mononuclear cells in atopic dermatitis | Q70124218 | ||
| Soluble E-selectin as a marker of disease activity in atopic dermatitis | Q73128470 | ||
| Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine | Q74527777 | ||
| Macrophage-derived chemokine is localized to thymic medullary epithelial cells and is a chemoattractant for CD3(+), CD4(+), CD8(low) thymocytes | Q78225273 | ||
| P433 | issue | 2 | |
| P921 | main subject | macrophage | Q184204 |
| P304 | page(s) | 270-273 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis | |
| P478 | volume | 127 |
| Q39723114 | A Th1/Th2-associated chemokine imbalance during infancy in children developing eczema, wheeze and sensitization. |
| Q61800971 | A transcription factor PU.1 is critical for Ccl22 gene expression in dendritic cells and macrophages |
| Q52847195 | Aberrant Expression of Bacterial Pattern Recognition Receptor NOD2 of Basophils and Microbicidal Peptides in Atopic Dermatitis. |
| Q37249808 | Allergy and the skin |
| Q42619840 | Angelicae Dahuricae Radix Inhibits Dust Mite Extract-Induced Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice |
| Q26828477 | Atopic dermatitis: a candidate for disease-modifying strategy |
| Q40659263 | Both IL-4 and IL-13 inhibit the TNF-alpha and IFN-gamma enhanced MDC production in a human keratinocyte cell line, HaCaT cells |
| Q79951348 | CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli |
| Q34417523 | CCL22 regulates experimental autoimmune encephalomyelitis by controlling inflammatory macrophage accumulation and effector function |
| Q38236403 | CCR4 and its ligands: from bench to bedside |
| Q36168658 | Chemokine networks in atopic dermatitis: traffic signals of disease |
| Q81618796 | Chemokines and inflammatory skin diseases |
| Q51707713 | Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. |
| Q51047430 | Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma. |
| Q47745168 | Dietetic effects of oral intervention with mare's milk on the Severity Scoring of Atopic Dermatitis, on faecal microbiota and on immunological parameters in patients with atopic dermatitis |
| Q42791919 | Effect of Histamine H<sub>1</sub> Receptor Antagonists on TARC/CCL17 and MDC/CCL22 Production from CD14+ Cells Induced by Antigenic Stimulation in vitro |
| Q28828873 | Efficient Use of a Crude Drug/Herb Library Reveals Ephedra Herb As a Specific Antagonist for TH2-Specific Chemokine Receptors CCR3, CCR4, and CCR8 |
| Q36992632 | Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children |
| Q38195861 | Epidemiology of atopic dermatitis in Japan. |
| Q39272972 | Expression of macrophage-derived chemokine (CCL22) in atherosclerosis and regulation by histamine via the H2 receptor |
| Q39826210 | Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-gamma in HaCaT cells, a human keratinocyte cell line |
| Q51983885 | Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells. |
| Q48132224 | Identification of unique proteomic signatures in allergic and non-allergic skin disease. |
| Q37225474 | Immunological mechanisms behind the cystic fibrosis-ABPA link |
| Q34417644 | Immunomodulatory effect of water soluble extract separated from mycelium of Phellinus linteus on experimental atopic dermatitis. |
| Q53458589 | Inhibitory Effects of Heartwood Extracts ofBroussonetia kazinokiSieb on the Development of Atopic Dermatitis in NC/Nga Mice |
| Q39986110 | Inhibitory effect of a histamine 4 receptor antagonist on CCL17 and CCL22 production by monocyte-derived Langerhans cells in patients with atopic dermatitis |
| Q39638135 | Inhibitory effects of Cinnamomum cassia extract on atopic dermatitis-like skin lesions induced by mite antigen in NC/Nga mice |
| Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
| Q37755318 | Mechanisms of leukocyte trafficking in allergic diseases: insights into new therapies targeting chemokines and chemokine receptors |
| Q47316499 | Oxymatrine Sensitizes the HaCaT Cells to the IFN-γ Pathway and Downregulates MDC, ICAM-1, and SOCS1 by Activating p38, JNK, and Akt. |
| Q38071148 | Pathological mechanisms of skin homing T cells in atopic dermatitis |
| Q38196934 | Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4. |
| Q55073242 | Salvia plebeia suppresses atopic dermatitis-like skin lesions. |
| Q52011080 | Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. |
| Q44651656 | Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis |
| Q79293315 | Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis |
| Q35420502 | Specific immunotherapy in atopic dermatitis. |
| Q54454334 | T lymphocyte dynamics in methylisothiazolinone-allergic patients. |
| Q37326436 | The Chloroform Fraction of Carpinus tschonoskii Leaves Inhibits the Production of Inflammatory Mediators in HaCaT Keratinocytes and RAW264.7 Macrophages |
| Q37326256 | The Inhibitory Effect of Premature Citrus unshiu Extract on Atopic Dermatitis In Vitro and In Vivo |
| Q37275230 | The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis |
| Q51643991 | The monocyte-derived chemokine is released in the bronchoalveolar lavage fluid of steady-state asthmatics. |
| Q46765346 | The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis |
| Q46710832 | Therapeutic benefits of natural ingredients for atopic dermatitis |
| Q38195864 | Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis |
| Q44225641 | VIP and PACAP down-regulate CXCL10 (IP-10) and up-regulate CCL22 (MDC) in spleen cells |
Search more.